Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 2 , Pages 275-286 , June 2008

Arginine vasopressin in the treatment of vasodilatory septic shock

  • Cheryl L. Holmes, MD, FRCPC (Clinical Instructor)

      Affiliations

    • Tel.: +1 250 212 9450; Fax: +1 250 764 9083.
  • Keith R. Walley, MD, FRCPC (Professor of Medicine)

      Affiliations

    • Corresponding Author InformationCorresponding author. Keith R. Walley, MD, UBC McDonald Research Laboratories, St. Paul's Hospital, 1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6. Tel.: +604 806 8136; Fax: +604 806 8351.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Support: Heart & Stroke Foundation of B.C. and Yukon. Keith R. Walley is a B.C. Lung Association/St. Paul's Hospital Foundation Scientist.

PII: S1521-6896(08)00026-8

doi: 10.1016/j.bpa.2008.03.002

Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 2 , Pages 275-286 , June 2008